Blueshift Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,325
Closed -$345K 392
2024
Q4
$345K Buy
+1,325
New +$393K 0.13% 226
2023
Q3
Sell
-2,246
Closed -$499K 276
2023
Q2
$499K Buy
+2,246
New +$521K 0.19% 136
2023
Q1
Sell
-1,762
Closed -$463K 331
2022
Q4
$463K Buy
1,762
+806
+84% +$216K 0.21% 129
2022
Q3
$215K Buy
+956
New +$232K 0.05% 494
2022
Q2
Sell
-5,516
Closed -$1.33M 665
2022
Q1
$1.33M Buy
5,516
+929
+20% +$213K 0.12% 212
2021
Q4
$1.03M Sell
4,587
-8,456
-65% -$1.78M 0.09% 293
2021
Q3
$2.77M Buy
13,043
+10,852
+495% +$2.5M 0.16% 178
2021
Q2
$534K Buy
2,191
+30
+1% +$7.38K 0.03% 542
2021
Q1
$538K Buy
+2,161
New +$516K 0.06% 444
2020
Q2
Sell
-1,315
Closed -$267K 508
2020
Q1
$267K Buy
+1,315
New +$287K 0.25% 104
2019
Q4
Sell
-1,442
Closed -$279K 778
2019
Q3
$279K Buy
+1,442
New +$277K 0.04% 544
2019
Q1
Sell
-2,840
Closed -$553K 680
2018
Q4
$553K Buy
+2,840
New +$554K 0.1% 326

Other funds holding AMGN

Blueshift Asset Management's AMGN Position: Q1 2025 in Review

Blueshift Asset Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,325 shares — an estimated $345K sold.

Blueshift Asset Management first reported a position in AMGN in Q4 2018 and held it in 12 quarters. The position peaked at $2.77M in Q3 2021. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Blueshift Asset Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 1,325 Amgen shares in Q1 2025, an estimated $345K.
  • Blueshift Asset Management first reported a position in Amgen in Q4 2018 and held it in 12 quarters.
  • Blueshift Asset Management's Amgen position peaked at $2.77M in Q3 2021.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Blueshift Asset Management's 13F filing for Q1 2025, filed 8 May 2025.